You are currently on the new version of our website. Access the old version .

Livers, Volume 4, Issue 3

2024 September - 13 articles

Cover Story: Cell-death-inducing DNA fragmentation factor-alpha (DFFA)-like effector b (CIDEB) was first identified as an apoptosis-inducing protein. Further research revealed a pivotal role in lipid metabolism, regulating very-low-density lipoprotein (VLDL), lipid droplets (LDs), sterol response element-binding protein (SREBP), and chylomicrons. Recent studies have uncovered that rare germline variants in CIDEB protect against liver diseases, including MAFLD, cirrhosis, and viral hepatitis. Furthermore, CIDEB influences steps of the hepatitis C virus (HCV) replication cycle. This review summarizes the current knowledge about CIDEB’s roles in apoptosis, lipid metabolism, and viral hepatitis, and highlights its critical role in liver diseases. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

  • Review
  • Open Access
6 Citations
6,617 Views
16 Pages

23 September 2024

Intestinal mucus serves as the first line barrier within the mucosa to protect against microbiota attack due to its water-repellent properties, which are the result of the high abundance of phosphatidylcholine bound to mucins. A deficiency of mucus p...

  • Review
  • Open Access
7 Citations
7,544 Views
24 Pages

13 September 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses metabolic dysfunction-associated fatty liver (MASL) and metabolic dysfunction-associated steatohepatitis (MASH), with MASH posing a risk of progression to cirrhosis and hepa...

  • Review
  • Open Access
7 Citations
11,559 Views
20 Pages

Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease

  • Samradhi Singh,
  • Mona Kriti,
  • Roberto Catanzaro,
  • Francesco Marotta,
  • Mustafa Malvi,
  • Ajay Jain,
  • Vinod Verma,
  • Ravinder Nagpal,
  • Rajnarayan Tiwari and
  • Manoj Kumar

12 September 2024

Non-alcoholic fatty liver disease (NAFLD) has emerged as a significant global health issue. The condition is closely linked to metabolic dysfunctions such as obesity and type 2 diabetes. The gut–liver axis, a bidirectional communication pathway...

  • Review
  • Open Access
2 Citations
6,893 Views
15 Pages

Transplant Immunology in Liver Transplant, Rejection, and Tolerance

  • Masaya Yokoyama,
  • Daisuke Imai,
  • Samuel Wolfe,
  • Ligee George,
  • Yuzuru Sambommatsu,
  • Aamir A. Khan,
  • Seung Duk Lee,
  • Muhammad I. Saeed,
  • Amit Sharma and
  • David A. Bruno
  • + 3 authors

9 September 2024

Liver transplantation is the most effective treatment for end-stage liver disease. Despite improvements in surgical techniques, transplant rejection remains a significant concern. The liver is considered an immune-privileged organ due to its unique m...

  • Review
  • Open Access
1 Citations
5,762 Views
14 Pages

Unveiling the Multifaceted Role of CIDEB: From Apoptosis to Lipid Metabolism and Liver Health

  • Louise Wutsdorff,
  • Julienne Mougnekabol,
  • Peter Tang,
  • Anja Reutzel-Selke,
  • Igor M. Sauer and
  • Nils Haep

27 August 2024

Cell-death-inducing DNA fragmentation factor-alpha (DFFA)-like effector b (CIDEB) was first identified as an apoptosis-inducing protein. Further research revealed a pivotal role in lipid metabolism, regulating very-low-density lipoprotein (VLDL), lip...

  • Case Report
  • Open Access
2,012 Views
8 Pages

Aggressive Surgical Management of Bilateral Metachronous Lung Metastases in Fibrolamellar Hepatocellular Carcinoma, a Case Report

  • Samuele Nicotra,
  • Luca Melan,
  • Alberto Busetto,
  • Alessandro Bonis,
  • Luigi Lione,
  • Vincenzo Verzeletti,
  • Federica Pezzuto,
  • Andrea Dell’Amore,
  • Fiorella Calabrese and
  • Federico Rea

21 August 2024

Fibrolamellar hepatocellular carcinoma (FL-HCC) is a malignant primary hepatic cancer that affects mainly adolescents and young adults without underlying liver disease. Its biology remains unknown, but it is pathologically distinct from traditional H...

  • Article
  • Open Access
1,862 Views
10 Pages

Predominance of Genotype 5 Hepatitis Delta Virus Infection in a Portuguese Hepatology Unit

  • Mariana Ferreira Cardoso,
  • Henrique Coelho,
  • Joana Carvalho e Branco,
  • Sofia Bragança,
  • Gonçalo Alexandrino,
  • Mariana Nuno Costa,
  • Rita Carvalho,
  • Elizabeth Pádua and
  • Alexandra Martins

21 August 2024

Hepatitis delta virus (HDV) infection is the most severe form of viral hepatitis. Genotype 1 (HDV-1) is by far the most prevalent in Europe and globally, while HDV-5 predominates in Western Africa. Data about HDV seroprevalence in Portugal are scarce...

  • Review
  • Open Access
3 Citations
4,097 Views
11 Pages

Targeting Autophagy for Acetaminophen-Induced Liver Injury: An Update

  • Kaitlyn Hinz,
  • Mengwei Niu,
  • Hong-Min Ni and
  • Wen-Xing Ding

14 August 2024

Acetaminophen (APAP) overdose can induce hepatocyte necrosis and acute liver failure in experimental rodents and humans. APAP is mainly metabolized via hepatic cytochrome P450 enzymes to generate the highly reactive metabolite N-acetyl-p-benzoquinone...

  • Article
  • Open Access
3,182 Views
13 Pages

The Hepatitis B Virus PreS1/HBsAg Ratio Is a Predictive Marker for the Occurrence of Hepatocellular Carcinoma

  • Masanari Kosaka,
  • Hatsue Fujino,
  • Masataka Tsuge,
  • Shinsuke Uchikawa,
  • Atsushi Ono,
  • Eisuke Murakami,
  • Tomokazu Kawaoka,
  • Daiki Miki,
  • C. Nelson Hayes and
  • Shiro Oka

2 August 2024

The preS1 region of the large hepatitis B virus (HBV) surface protein is a crucial component in HBV infection; however, its impact on the development of hepatocellular carcinoma (HCC) remains unknown. This study investigated the relationship between...

  • Article
  • Open Access
1,403 Views
12 Pages

Useful Predictor for Exacerbation of Esophagogastric Varices after Hepatitis C Virus Eradication by Direct-Acting Antivirals

  • Yuko Nagaoki,
  • Kenji Yamaoka,
  • Yasutoshi Fujii,
  • Shinsuke Uchikawa,
  • Hatsue Fujino,
  • Atsushi Ono,
  • Eisuke Murakami,
  • Tomokazu Kawaoka,
  • Daiki Miki and
  • Shiro Oka
  • + 3 authors

30 July 2024

To clarify the risk factors for the aggravation of esophagogastric varices (EGVs) after hepatitis C virus (HCV) eradication with direct-acting antiviral (DAA) therapy, we enrolled 167 consecutive patients with HCV-related compensated cirrhosis who ac...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Livers - ISSN 2673-4389